Future therapeutic treatment of COPD: struggle between oxidants and cytokines
about
L-2-Oxothiazolidine-4-carboxylic acid or α-lipoic acid attenuates airway remodeling: involvement of nuclear factor-κB (NF-κB), nuclear factor erythroid 2p45-related factor-2 (Nrf2), and hypoxia-inducible factor (HIF)Impact of anti-inflammatory agents on the gene expression profile of stimulated human neutrophils: unraveling endogenous resolution pathwaysAnti-inflammatory effect of a selective IkappaB kinase-beta inhibitor in rat lung in response to LPS and cigarette smoke.Proteinase-activated receptor-2 up-regulation by Fcgamma-receptor activation in human neutrophilsHhip haploinsufficiency sensitizes mice to age-related emphysemaOxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy.Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.Chronic obstructive pulmonary disease: an update of treatment related to frequently associated comorbidities.High-fat diet induces lung remodeling in ApoE-deficient mice: an association with an increase in circulatory and lung inflammatory factors.Recuperating Lung Decoction Attenuates the Oxidative Stress State of Chronic Obstructive Pulmonary Disease by Inhibiting the MAPK/AP-1 Signal Pathway and Regulating γ-GCS.Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease.Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer.The Function of Ophiocordyceps sinensis in Airway Epithelial Cell Senescence in a Rat COPD Model.Hydrogen Sulfide Protects against Chemical Hypoxia-Induced Injury via Attenuation of ROS-Mediated Ca Overload and Mitochondrial Dysfunction in Human Bronchial Epithelial Cells
P2860
Q28387954-EAA34E4E-8CAB-4ED8-9B43-4B02C471E2E1Q33419375-68DA8218-B87B-4E1D-A406-DE57FD6E6D5FQ33774669-E8A99DCC-F32F-4A85-84CF-406277C601DCQ33895918-4A124B2E-DBBF-4BB7-8F26-EB5945E60D27Q34534888-B1CC444C-C6EF-4D68-AF8F-D24B086E92E7Q35841917-8DAE432E-A5A2-4849-B12F-0F166361C73AQ36426923-3E0D86CC-3D35-4AFE-AEC2-8E07EA0FA5F1Q36443665-1838650E-9461-49E9-8DD0-DD633441C4E1Q37441933-183F6754-14DE-4D5C-99FB-72E3F5A03882Q37734369-61303C38-5C35-42CD-971B-F0F5CCE1DC5DQ37836078-67963BFC-DDF8-431E-BD3D-4BED44D09ED6Q38166232-DBC6BFF0-51F0-44F4-B42E-2D78C5833B81Q55227397-7283FFED-C03E-4300-9425-E9F923F00276Q58603899-D386C276-10F5-4654-9DC1-FE842E33CC11
P2860
Future therapeutic treatment of COPD: struggle between oxidants and cytokines
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Future therapeutic treatment of COPD: struggle between oxidants and cytokines
@en
Future therapeutic treatment of COPD: struggle between oxidants and cytokines.
@nl
type
label
Future therapeutic treatment of COPD: struggle between oxidants and cytokines
@en
Future therapeutic treatment of COPD: struggle between oxidants and cytokines.
@nl
prefLabel
Future therapeutic treatment of COPD: struggle between oxidants and cytokines
@en
Future therapeutic treatment of COPD: struggle between oxidants and cytokines.
@nl
P2093
P2860
P1476
Future therapeutic treatment of COPD: struggle between oxidants and cytokines
@en
P2093
Hongwei Yao
Irfan Rahman
Willem I de Boer
P2860
P304
P407
P577
2007-01-01T00:00:00Z